BofA on Jazz (JAZZ): 'We continue to see $1bn+ peak sales potential for zani in 1L GE'
Go back to BofA on Jazz (JAZZ): 'We continue to see $1bn+ peak sales potential for zani in 1L GE'| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 230.93 +4.81 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $226.12 | 52 Week High | $160.00 | |||
| Open | $226.11 | 52 Week Low | $95.80 | |||
| Day High | $231.49 | P/E | 42.92 | |||
| Day Low | $224.99 | EPS | $5.38 | |||
| Volume | 910,550 | |||||
